Navitoclax (ABT-263)
Product Specifications
CAS Number
923564-51-6
Target
Bcl-2
Applications
Apoptosis
Smiles
CC1 (CCC (=C (C1) CN2CCN (CC2) C3=CC=C (C=C3) C (=O) NS (=O) (=O) C4=CC (=C (C=C4) NC (CCN5CCOCC5) CSC6=CC=CC=C6) S (=O) (=O) C (F) (F) F) C7=CC=C (C=C7) Cl) C
Molecular Formula
C47H55ClF3N5O6S3
Additionnal Information
Navitoclax (ABT-263) is a potent inhibitor of Bcl-xL, Bcl-2 and Bcl-w with Ki of ≤ 0.5 nM, ≤1 nM and ≤1 nM in cell-free assays, but binds more weakly to Mcl-1 and A1. Phase 2.
Storage Conditions
2 years -80 in solvent
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
EK2011-carrier-free 96 Well With Removable Strips
Mouse Ly9/SLAMF3/CD229 ELISA Kit PicoKine®, Carrier-free
Sign In for Pricing
View Details A136000 100 µL
Efdamrofusp Alfa Biosimilar (, Fusion - FLT1 (fms-related tyrosine kinase 1, vascular endothelial growth factor receptor 1, VEGFR-1, VEGFR, FLT, FRT, vascular permeability factor receptor) domain 2 fragment (14-204) - KDR (kinase insert domain receptor, vascular endothelial growth factor receptor 2, VEGFR2, VEGF-R2, FLK1, CD309) domain 3 fragment (206-308) - IGHG1 Fc (Fragment constant (205-431) ) - CR1 (complement receptor type 1, C3b/C4b receptor, C3BR, Knops blood group, KN, CD35) fragment (1-192) )
Sign In for Pricing
View Details 
MBS1247059-01 0.02 mg (E-Coli)
Recombinant Brevibacillus brevis Phosphoribosylformylglycinamidine cyclo-ligase (purM)
Sign In for Pricing
View Details MBS1247059-02 0.02 mg (Yeast)
Recombinant Brevibacillus brevis Phosphoribosylformylglycinamidine cyclo-ligase (purM)
Sign In for Pricing
View Details MBS1247059-03 0.1 mg (E-Coli)
Recombinant Brevibacillus brevis Phosphoribosylformylglycinamidine cyclo-ligase (purM)
Sign In for Pricing
View Details MBS1247059-04 0.1 mg (Yeast)
Recombinant Brevibacillus brevis Phosphoribosylformylglycinamidine cyclo-ligase (purM)
Sign In for Pricing
View Details